US Physical Therapy CFO granted 6,831 shares

USPH granted its EVP & CFO 6,831 shares of time-vested restricted stock that vest in installments through 2030, subject to continued employment.

Rhea-AI Filing Summary

U S PHYSICAL THERAPY INC /NV (symbol: USPH) is the issuer of record for a Form 4 filing submitted to the SEC. Etta Nchacha reported acquisition or exercise transactions in this Form 4 filing.

U S PHYSICAL THERAPY INC /NV (USPH) reported that its EVP & Chief Financial Officer, Etta Nchacha, received a grant of 6,831 shares of Common Stock on September 14, 2026. The award is in the form of restricted stock granted under the company's Amended and Restated 2003 Stock Incentive Plan.

The 6,831 restricted shares will vest in service-based installments: 427 shares on each of 15 dates from November 20, 2026 through May 20, 2030, and 426 shares on August 20, 2030, in each case subject to her continued employment through the applicable vesting date. After this grant, she holds 6,831 shares directly. No Rule 10b5-1 trading plan is reported.

Insider Trade Summary

Grant/Award: 6,831 shares

Grant/Award 1 txn

Insider Etta Nchacha

Role EVP & Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	6,831	$0.00	$0.00

Holdings After Transaction: Common Stock — 6,831 shares (Direct)

Footnotes (1)

1. F1. Includes 6,831 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 427 shares will vest on each of November 20, 2026, March 6, 2027, May 20, 2027, August 20 2027, November 20, 2027, March 6, 2028, May 20, 2028, August 20 2028, November 20, 2028, March 6, 2029, May 20, 2029, August 20 2029, November 20, 2029, March 6, 2030, and May 20, 2030, and 426 shares will vest on August 20, 2030. Vesting is subject to his continued employment with the Company through each of the applicable vesting dates.

Key Figures

Restricted stock granted: 6,831 shares Price per share for grant: $0.00 per share Shares held after transaction: 6,831 shares +2 more

5 metrics

Restricted stock granted 6,831 shares Common Stock awarded to EVP & CFO on September 14, 2026

Price per share for grant $0.00 per share Compensation-related restricted stock grant, not a market purchase

Shares held after transaction 6,831 shares Total direct holdings of the CFO following the grant

Standard vesting tranche size 427 shares Number of shares vesting on each of 15 scheduled vesting dates

Final vesting tranche size 426 shares Number of shares vesting on August 20, 2030

Key Terms

restricted stock, Amended and Restated 2003 Stock Incentive Plan, vesting, continued employment

4 terms

restricted stock financial

"Includes 6,831 shares which were granted as restricted stock pursuant"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Amended and Restated 2003 Stock Incentive Plan financial

"granted as restricted stock pursuant to the Company's Amended and Restated 2003"

vesting financial

"Restrictions lapse as follows: 427 shares will vest on each of"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

continued employment financial

"Vesting is subject to his continued employment with the Company"

Continued employment means that an individual remains in their current job without interruption. For investors, it signals stability and ongoing work that can affect company performance and future prospects. Like a steady heartbeat for a business, sustained employment helps ensure consistent operations and financial health.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did USPH EVP & CFO Etta Nchacha report on this Form 4 for USPH?

She reported receiving a grant of 6,831 shares of USPH Common Stock as restricted stock on September 14, 2026, under the company’s Amended and Restated 2003 Stock Incentive Plan. The grant is compensation-related and not a market purchase or sale.

How many USPH shares does the CFO hold after this reported transaction?

After the reported grant, Etta Nchacha holds 6,831 shares of USPH Common Stock directly. All of these shares are in the form of restricted stock that will vest over time, subject to her continued employment with the company.

What is the vesting schedule for the 6,831 restricted USPH shares granted to the CFO?

The award vests in installments: 427 shares on each of November 20, 2026; March 6, 2027; May 20, 2027; August 20, 2027; November 20, 2027; March 6, 2028; May 20, 2028; August 20, 2028; November 20, 2028; March 6, 2029; May 20, 2029; August 20, 2029; November 20, 2029; March 6, 2030; May 20, 2030, and 426 shares on August 20, 2030.

Is the CFO’s USPH restricted stock grant subject to any conditions?

Yes. The filing states that vesting is subject to her continued employment with U S PHYSICAL THERAPY INC /NV through each of the applicable vesting dates. If employment ends before a vesting date, unvested shares may not vest.

Was the USPH CFO’s restricted stock grant made under a Rule 10b5-1 plan?

No. The Form 4 indicates that no Rule 10b5-1 trading plan is reported for this transaction. It is described as a grant or award acquisition rather than a trade executed under a pre-arranged trading plan.

What price per share is listed for the USPH restricted stock grant to the CFO?

The Form 4 lists a transaction price of $0.00 per share for the 6,831 restricted shares, consistent with a compensation-related grant rather than a market purchase. The grant was made under the company’s stock incentive plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/15/2026 - 04:09 PM Accepted by SEC EDGAR 09/15/2026 - 04:09 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Etta Nchacha

(Last) (First) (Middle)

1300 W SAM HOUSTON PKWY S

SUITE 300

(Street)

HOUSTON TEXAS 77042

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
U S PHYSICAL THERAPY INC /NV [ USPH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/14/2026		A		6,831	A	$0.00	6,831(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 6,831 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 427 shares will vest on each of November 20, 2026, March 6, 2027, May 20, 2027, August 20 2027, November 20, 2027, March 6, 2028, May 20, 2028, August 20 2028, November 20, 2028, March 6, 2029, May 20, 2029, August 20 2029, November 20, 2029, March 6, 2030, and May 20, 2030, and 426 shares will vest on August 20, 2030. Vesting is subject to his continued employment with the Company through each of the applicable vesting dates.

	/s/ Kate Venturina, as attorney-in-fact	09/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)